Authors
Loading...
Review highlights immune microenvironment signatures affecting response to immune checkpoint inhibitors, suggesting new predictive biomarkers for better patient stratification.
Ayobami et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: